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A B S T R A C T
Objective: The present study analyzed long-term outcomes and complications of laparoscopic lateral
suspension (LLS) with mesh to treat apical and anterior pelvic organ prolapse (POP).
Study design: A prospective cohort study on 125 patients with vaginal bulge and apical +/ anterior
prolapse scheduled for LLS who consecutively underwent LLS between April 2013 and January 2017 in
Gynecologic Department of Santa Chiara Hospital in Trento and University of Pisa.
The main outcome measure was anatomic and symptomatic POP outcome; the secondary outcomes
measures were recurrence, reoperation rate, de novo posterior POP and complications. Percentage
distribution of the pre- and postoperative POP-Q stages was compared at mean follow-up. Wilcoxon
signed rank sum test was used to compare preoperative POP-Q stage and postoperative POP-Q stage ate
mean follow up, for each patient (paired data) and for each type of prolapse.
Results: 120 patients were included in the study. At 2 years 89 % of patients were asymptomatic and
anatomic success rate was 94.2 % for the anterior compartment, 94.9 % for the apical compartment.
Concerning posterior compartment prolapse 2 (1.7 %) patients referred stage 3 de novo prolapse during
follow-up. The complication rate of Clavien-Dindo >3 was 0,8 %. Repeat surgery for POP occurred in 6.4 %
of cases. The appearance of POP-Q recurrences was concentrated at 6 months follow-up. BMI > 25 was
correlated with de novo posterior compartment appearance during follow-up.
Conclusions: LLS for the treatment of apical and anterior POP is a technique with optimal results in term of
safety and effectiveness after 2 years follow-up.
© 2019 Elsevier B.V. All rights reserved.
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POP is a frequent condition and can affect a woman’s quality of
life. In post-menopausal women, the prevalence of POP is 3–6%
when deﬁned and graded on symptoms compared with 41–50 %
when based on examination [1,2]. The anterior compartment is the
most frequently reported site of prolapse, it is identiﬁed twice
more than posterior and three times more than apical compart-
ment defect [3]. Only 10–20% of affected women, though, seek
evaluation for their condition [2]. Although surgery is generally* Corresponding author at: Department of Obstetrics and Gynecology, Ospedale
Santa Chiara, Trento Largo Medaglie d’Oro 9, 38122, Trento, Italy.
E-mail address: liliana.mereu@apss.tn.it (L. Mereu).
https://doi.org/10.1016/j.ejogrb.2019.10.026
0301-2115/© 2019 Elsevier B.V. All rights reserved.reserved to patients with prolapse symptoms, with advance stage
or after failure of conservative treatments, woman’s lifetime risk of
surgery for POP is 12–19% [4].
There are various surgical techniques for the correction of POP:
fascial vs mesh repair, vaginal vs abdominal route and different
abdominal approaches: laparotomy, laparoscopy, robot-assisted
laparoscopy. After the FDA warning of 2011 and 2019 concerning
POP repair with vaginal mesh, trans-abdominal mesh procedures
have reached the more favourable risk-beneﬁt proportion for
correction of apical defect. By some, sacrocolpopexy (SCP) is
considered the gold standard [2] even if it can be associated with
long operative time and learning curve, serious morbidity as
vascular and ureteric injuries, lesions of the superior hypogastric
plexus, right hypogastric nerve leading to de novo constipation and
even if rare spondylodiscitis and lumbar pain [5–7].
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promontory could be LLS. This procedure provides symmetrical
lateral tension-free suspension of the central mesh part attached to
the vagina and it can be performed with or without uterus
preservation or after hysterectomy. Kapandgji described lateral
suspension the ﬁrst time in 1967 [8]. Then Dubuisson modiﬁed the
technique for laparoscopic approach in 1998 [9], to treat anterior
and apical compartment POP, reporting good results in term of
absence of complications and POP recurrences after one year of
clinical follow-up [10]. Recently Mini-laparoscopic and Robotic
approaches have also been described with optimal results in term
of feasibility, learning curve and complications [11,12].
The aim of this study was to analyze POP outcomes and safety of
LLS for apical and anterior POP.
Material and methods
This is a prospective cohort study of consecutive patients who
underwent LLS for apical and anterior POP between April 2013 and
January 2017 at the Gynecological Unit of the S. Chiara Hospital of
Trento and at the Division of Obstetrics and Gynecology of the
University of Pisa. Inclusion criteria were: symptomatic stage 2 or
greater (point C > -1 pelvic organ prolapse quantiﬁcation POP-Q)
apical prolapse (uterovaginal or vault prolapse) with or without
anterior compartment prolapse (point Ba > -1 pelvic organ
prolapse quantiﬁcation POP-Q) and without symptomatic or
signiﬁcant posterior compartment prolapse (point Bp> 1 pelvic
organ prolapse quantiﬁcation POP-Q).
Exclusion criteria: patients who underwent LLS with abdominal
fascia ﬁxation of the mesh. Patients with apical +/-anterior and
posterior prolapse underwent sacrocolpopexy. Informed consent
to LLS was obtained from all patients in accordance with local
legislation.
Institutional Review Board approval was obtained from both
the Ethical Committee of Azienda Provinciale Servizi Sanitari of
Trento and the University of Pisa.
Pre-treatment evaluation included: medical history collection,
pelvic ultrasound, physical examination, clinical evaluation of
pelvic organ support assessed by the Pelvic Organ Prolapse
Quantiﬁcation Grading system (POP-Q). Clinical patient character-
istics including age, BMI, menopausal hormonal status, sexual
activity, parity, dyspareunia, bladder dysfunctions, intestinal
symptoms such as constipation and fecal incontinence, co-
morbidity and prior surgery for POP were recorded. Intraoperative
parameters including concomitant surgery, overall operating time,
blood loss, conversion rate, post-operative pain, complications,
time to discharge and recurrence were recorded as well. The
estimated blood loss (EBL) was calculated by the difference in the
total amounts of suctioned and irrigation ﬂuids. Operative time
was deﬁned as the time from skin incision to the skin closure.
Perioperative, early postoperative complications ( 30 days) and
late postoperative complications (> 30 days) were recorded.
Dyspareunia was recorded using a Numerical Rating Scale (NRS)
from 1 to 10 (dyspareunia > 4 has been considered clinically
relevant). Bladder dysfunctions were classiﬁed in urinary stress
incontinence, urge incontinence and voiding dysfunction. Postvoid
residual volume meausrement and urodynamic evaluation have
been performed when required in relation to patients’ symptoms
[13]. The Incontinence Impact Questionaire 7 (IIQ7) was used to
assess the impact of UI [14], defecatory functional status was
assessed by the Wexner constipation score [15]. Intraoperative
complications were scored according to Classiﬁcation of Intra-
operative Complications [16] and postoperative complications
according to the “Clavien–Dindo classiﬁcation of surgical compli-
cations scale’’ [17]. Mesh-related complications were classiﬁed
using the IUGA/ICS complication classiﬁcation [18]. Postoperativepain assessment was performed using NRS. Systematic postopera-
tive clinical and symptomatic evaluation were performed at 6
weeks, 6 months, one and 2 years. Anatomic cure was deﬁne as
POP-Q Ba, C, Bp < +1 cm, while subjective outcomes were
determined by asking to the patients about presence of
bulge symptoms. The main outcomes measures were anatomic
and symptom outcomes; the secondary outcome measures
were recurrence, reoperation rate, de novo posterior POP and
complications.
In absence of uterine disease, hysteropexy was the ﬁrst choice.
LLS technique described by Dubuisson et al. [19] has been adopted
not only for the laparoscopic but also for the mini-laparoscopic and
robotic approach [16,20]. In all cases a titanium-coated macro-
porous polypropylene mesh (TiLOOP1Dubuisson) was used.
Statistical analysis
An initial overview of the sample was obtained through the
creation of a frequency distribution table (absolute and percent-
age) of demographic and clinical variables. The mean standard
deviation and median values were presented for the age of
patients.
The wilcoxon signed rank sum test was used to compare
preoperative POP-Q stage and postoperative POP-Q stage at mean
follow up, for each patient (paired data) and for each type of
prolapse. This statistical test has been chosen because the
difference between the two variables is not normally distributed
and the variables are ordinal. Mean values and SD are also
presented for each group.
The signiﬁcance of the association between the postoperative
POP-Q stage and couples of times of follow-up (6 weeks vs. 6
months and 6 months vs. 12 months) was analyzed with Fisher-s
Exact test, considering the association signiﬁcant when the p-value
was <0.05.
The univariate analysis took into account the associations
between independent variables (such as type of minimal invasive
approach, BMI classes, age classes, parity, hormonal status and
prior POP surgery) and the outcome variables (type of recurrence
of POP, repeat surgery for POP, surgery for different site, surgery for
complications, vaginal bulge, de novo symptomatic posterior and
asymptomatic POP  3): these associations were all invariably
studied with Fisher’s Exact test.
Results
125 patients consecutively underwent to LLS; 5 patients were
excluded because submitted to a modiﬁed LLS with mesh attached
to abdominal fascia.
Patient characteristics and preoperative symptoms are shown
in Table 1.
Indication to LLS was, in all cases, the presence of vaginal bulge
and apical +/- anterior prolapse. Apical prolapse >3 was present
preoperatively in 96(80,6 %) patients, anterior compartment defect
>3 in 86(72.3 %) patients and vaginal bulge in all cases.
Intraoperative ﬁndings are shown in Table 2.
The Foley catheter was removed on the morning after surgery.
Mean hospital stay was 2.1 days (range 1–10). Mean length of
postoperative follow up was 20 months: all patients had a follow-
up at 6 weeks, 6 and 12 months, and 89 at 24 months.
Postoperative complications at 1 month occurred in 7 cases, 2
patients grade 1: pain and vaginitis, 1 patient grade 2: pyelone-
phritis requiring IV antibiotics therapy and 10 days of hospitaliza-
tion, 1 patients grade 3: 1 mesh erosion requiring vaginal excision
of mesh exposure. No grade IV complications occurred.
Concerning urogynecological de novo symptoms: 7 (5.8 %)
urgency, 3 (2.5 %) stress urinary incontinence (SUI), 3 (2.5 %)
Table 1
Patients’ characteristics.
All patients
(n = 120)
Caucasian ethnicity, n (%) 120 (100)
Age (years), mean  SD (median) 60  9.85 (61)
BMI (kg/m2) <25, n (%) 66 (55)
BMI (kg/m2) >25, n (%) 59 (49.1)
Parity, n (%)
Nulliparous 1 (0.8)
Multiparous 119 (99.21
Number of vaginal deliveries, n (%)
One 42 (35)
Two or more 81 (67.2)
Menopausal, n (%) 100 (83.3)
HRT, n (%) 7 (5.8)
Sexual activity, n (%) 96 (80)
Dyspareunia > 4, n (%) 11 (9.1)
Voiding obstruction, n (%) 4 (3.3)
Stress Incontinence, n (%) 0 (0)
Urgency incontinence, n (%) 11 (9.1)
Constipation, n (%) 0 (0)
Fecal incontinence, n (%) 0 (0)
Prior POP surgery, n (%) 13 (10.8)
Prior urinary incontinence surgery, n (%) 3 (2.5)
Prior hysterectomy, n (%) 7 (5.8)
BMI = Body Mass Index.
HRT = Hormone Replacement Therapy.
Voiding obstruction includes symptoms of hesitancy, weak stream, incomplete
empyting.
Table 2
Surgical ﬁndings.
All patients (n = 120)
Approaches
Standard laparoscopy, n(%) 40 (33.3)
Mini-laparoscopy, n (%) 20 (16.6)
Robotic assisted laparoscopy, n(%) 60 (50.0)
Suspension
Hystero 105 (87.5)
cervical 8 (6.6)
Vaginal vault 7 (5.8)
Anterior mesh, n (%) 120 (100%)
Posterior mesh n, (%) 0 (0%)
Concomitant procedures, n (%) 45 (37.5)
Total hysterectomy, n 1
Subtotal hysterectomy, n 7
Myomectomy, n 2
Salpingoophorectomy, n 12
Salpingectomy, n 7
Cervical amputation 7
Stapled transanal rectal resection, n 2
Hysteroscopic polipectomy, n 2
Adhesiolysis, n 5
Mean operative time, mean (range) 120 (63-280)
Intraoperative complications, n (%) 0 (0)
Conversion to laparotomy n, (%) 0 (0)
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asymptomatic patients. No patient developed de novo constipa-
tion, fecal incontinence or dyspareunia and 11 women who had
preoperative dyspareunia improved after surgery. Urgency incon-
tinence was resolved with medical treatment (topic estrogen) and
the three cases of SUI did not require any surgery at the moment.
At 2 years 89 % of patients were asymptomatic and anatomic
success rate was 94.2 %.
Anatomical results are detailed in Table 3.
During the follow up we observed the following recurrences: 6
(5 %) stage 3 anterior compartment, 1 (0.8 %) stage 4 anteriorcompartment, 5(4.2 %) stage 3 apical compartment, 1 (0.8 %) stage
4 apical compartment. Concerning posterior compartment pro-
lapse we had 2 (1.6 %) stage 3 and no stage 4 de novo prolapses.
Vaginal bulging occurred in 14 (11.7 %) cases and de novo
symptomatic posterior prolapse in 1 (0.8 %) women. A total of 8
(6.7 %) patients underwent subsequent SCP because of symptom-
atic prolapse: 1 patient for concomitant anterior, apical and
posterior prolapse stage 4, 6 for anterior and apical stage 3 and 1
for posterior stage 3. No patient underwent subsequent surgery for
stress incontinence.
The recurrences of stage 3 and 4 are concentrated at 6 months
follow-up with a statistical signiﬁcantly difference from the
recurrence at 6 weeks and 12 months (anterior compartment
p = 0.007, apical compartment p = 0.001, posterior compartment
p = 0.032). Table 4. No signiﬁcantly difference has been found at 12
and 24 months.
Univariate analysis shows that only BMI > 25 is correlated with
de novo posterior compartment appearance during follow up
(p = 0.0278), while neither patients characteristics nor type of
surgery seems to inﬂuence anterior or apical prolapse recurrences,
vaginal bulge, repeat surgery for POP, or surgery complications
(p > 0.05).
Discussion
The present series of 120 patients mirrors a previous experience
of two centres that already published articles on LLS with mesh in
the treatment of genital prolapse [11,12,20].
In our opinion, indication is crucial for this kind of correction;
indeed, as already suggested by Dubuisson et al, relevant surgical
indications are hysterocele and/or cystocele; the procedure is not
indicated in case of predominant rectocele, enterocele and/or
pelvic ﬂoor insufﬁciency [10,21]. For this reason, we excluded
patients with apical and posterior defect, to whom we recommend
SCP, which provides reinforcement in the rectovaginal space and a
posterior direction of the vaginal axis [19]
LLS allows preservation of the uterus, thus providing a
signiﬁcant surgical, functional and psychological beneﬁt in term
of safety, reduction of operative time, anatomy preservation and
patient satisfaction [10]. In the present study 8 patients underwent
supracervical hysterectomy for symptomatic uterine myomas and
1 patient underwent total hysterectomy for absence of preopera-
tive endometrial assessment.
LLS can be performed with different approaches [11,12,21]. We
did not ﬁnd statistical difference in term of outcomes among
women underwent standard laparoscopy, minilaparoscopy or
robotic.
For all patients a titanium-coated macroporous polypropylene
mesh (TiLOOP1Dubuisson) was used: it is a hydrophilic material
that adheres more stably to the vaginal wall, with an easier
manipulation, optimal tissue engraftment and enhanced biocom-
patibility [22–24]. In the present series only one (0.8 %) mesh
erosion occurred, one month after surgery; the incidence is
signiﬁcantly lower compared with the 4 % cumulative incidence of
mesh erosion reported in a systematic review after abdominal
surgery with mesh during a 2-years follow up [25] and of 4,3 %
after 417 laparoscopic lateral suspension procedures [14] where
both microporouse and macroporouse mesh was utilized. It is well
known that Polypropylene is the mesh material that allows the
development of well-organized, ﬁbrous, mature connective tissue
[26–28] and a titanium layer over polypropylene seems to improve
the beneﬁts of polypropylene, as demonstrated in hernia repair
[24], notably reducing the risk of extrusion or exposure.
The overall objective success rate of 94 % and the overall
subjective cure rate of 89 % at 19 months of follow-up in both
anterior and apical compartment are comparable to the success
Table 3
Pre- and postoperative POP-Q stage at mean follow up.
POP-Q Preoperative n (%) Postoperative
at an average of 20 months n (%)
p-value Wilcoxon signed
rank sum test
Point Ba
0 1 (0.8) 88 (73.3)
<1 cm 7 (5.8) 15 (12.5)
 1 cm to 1 cm 20 (16.6) 10 (8.4) <0.0001
>1 cm to < (TVL-2) cm 69 (57.6) 6 (5)
 (TVL-2) cm 23 (191) 1 (0.8)
Mean (SD) 2.9 (0.8) 0.5 (0.9)
Point C
0 0 (0.0) 109 (90.8)
<1 cm 0 (0.0) 3 (2.5)
 1 cm to  1 cm 37 (30.8) 2 (1.6) <0.0001
>1 cm to < (TVL-2) cm 48 (40.0) 5 (4.1)
(TVL-2) cm 35 (29.1) 1 (0.8)
Mean (SD) 3.0 (0.8) 0.2 (0.7)
Point Bp
0 75 (62.5) 72 (60.0)
<1 cm 40 (33.3) 26 (21.6)
 1 cm to  1 cm 5 (4.1) 20 (16.6)
>1 cm to < (TVL-2) cm 0 (0.0) 2 (1.6) 0.02
 (TVL-2) cm 0 (0.0) 0 (0.0)
Mean (SD) 0.4 (0.6) 0.6 (0.8)
Table 4
De novo appearance of POP during follow-up.
Comparison between Postoperative 6 weeks and
Postoperative 6 months
Comparison between Postoperative 6 months and
Postoperative 12 months
Postoperative
6 weeks, (n = 120) n (%)
Postoperative
6 months
(n = 120) n (%)
Postoperative
6 months (n = 120) n (%)
Postoperative
12 months
(n = 120) n (%)
Point Ba
<1 cm 13 (10.8%) 4 (3.3%) 4 (3.3%) 5 (4.1%)
1 cm to 1 cm 10 (8.3%) 6 (5%) 6 (5%) 2 (1.6%)
>1 cm to <(TVL-2)cm 0 (0.0%) 6 (5%) 6 (5%) 0 (0.0%)
 (TVL-2) cm 0 (0.0%) 1 (0.8%) 1 (0.8%) 0 (0.0%)
p-value Fisher’s Exact test 0.007 0.11
Point C
<1 cm 7 (5.8%) 0 (0.0%) 0 (0.0%) 1 (0.8%)
 1 cm to  1 cm 3 (2.5%) 2 (1.6%) 2 (1.6%) 0 (0.0%)
> 1 cm to < (TVL-2) cm 0 (0.0%) 5 (4.1%) 5 (4.1%) 0 (0.0%)
 (TVL-2) cm 0 (0.0%) 1 (0.8%) 1 (0.8%) 0 (0.0%)
p-value Fisher’s Exact test 0.001 0.011
Point Bp
< 1cm 16 (13.3%) 9 (7.5%) 9 (7.5%) 2(1.6%)
 1 cm to  1 cm 4 (3.3%) 12 (10%) 12 (10%) 3 (2.5%)
> 1 cm to < (TVL-2) cm 0 (0.0%) 1 (0.8%) 1 (0.8%) 0 (0.0%)
 (TVL-2) cm 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
p-value Fisher’s Exact test 0.032 0.883
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vaginal bulge was reported by 11 % of patients. It is a better result if
compared with 21.6 % described in 417 laparoscopic lateral
suspension procedures for anterior, apical and posterior prolapse
by Veit-Rubin [29]. Only 8 patients (6.6 %) repeated surgery for POP
during two years of follow-up, which is consistent with the
ﬁndings of several investigators who reported re–operation rates
from 3.4–11% [29,30]. These low rates of objective and symptom-
atic prolapse recurrences indicate excellent outcomes of this
technique for the treatment of apical and anterior defect according
to the criteria described by Barber et al. [2].
With regard to the posterior compartment, we found de novo
posterior prolapse in 3 (2.5 %) patients; 1 de novo symptomatic and
2 de novo posterior POP-Q>3. Two patients underwent surgery
during follow-up for symptomatic posterior prolapse (one withconcomitant apical and anterior POP and one with only posterior
POP).
We found an association between appearance of postoperative
POP and time to follow up, the recurrence of anterior and apical
prolapse and the appearance of asymptomatic stage 1/2 posterior
prolapse were detected signiﬁcantly more often during the 6
month-follow up visit.
The univariate analysis reveals that only BMI >25 is related to de
novo posterior compartment defect > 2, while the type of surgical
approach, age, parity, menopausal hormonal status, prior POP
surgery seem not to have a signiﬁcant association with POP
recurrence, reintervention or POP symptoms. These ﬁndings suggest
that we could consider a concomitant preventative correction of the
posterior compartment in selected groups of patients or we could
advise weight loss prior to surgical POP correction.
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does not lead to enterocele or Pouch of Douglas hernia in patients
treated for apical and anterior prolapse; the identiﬁcation, during
the follow up of a 19 % of asymptomatic posterior POP-Q = 2 would
demonstrate that LLS reveals the presence of pre-existing posterior
defect rather than determines its appearance. While vaginal
sacrospinous or sacrocolpopexy clearly divert the physiologic axis
of the vagina, LLS seems not to change vaginal anatomy [31]. We do
not know whether or not the "correct" vaginal axis impacts pain or
sexual function. As these anatomic considerations are merely
hypothesises, further studies are needed to clarify these aspects.
The absence of dyspareunia after this surgical procedure seems
to preserve the normal sexual function. During the follow up we
also found a low rate (10 %) of urinary symptoms and no de novo
intestinal symptoms such as constipation and fecal incontinence.
In our cohort of patients who underwent standard LLS,
postoperative Clavien-Dindo grade 3 complications occurred only
in 1/119 (0.8 %) of cases.
The low incidence of postoperative complications and the high
success rate of this technique provide reason to consider LLS as an
option to treat apical and anterior POP.
This is the ﬁrst study on LLS with a clinical follow up of two
years (mean follow up of 20 months); the majority of previous
studies on LLS have a 12 month-follow-up with objective
evaluation [19,21], while the only study with a mean follow up
of 7.2 years is based on telephone interviews on patients’
satisfaction [10,28].
Weakness of the present study is the presence of different
minimal invasive approaches and differences in type of sutures
utilized. A multicenter randomized controlled study is ongoing,
comparing standardized LLS and SCP for the treatment of apical
defects.
Conclusion
This series of LLS with mesh procedures for the treatment of
anterior and apical prolapse performed by two institutions showed
that the technique is feasible and reproducible with optimal results
in term of safety and effectiveness, after 2 years follow up. However,
randomized controlled studies are needed to clarify if this technique
can be considered an alternative in the treatment of POP.
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